A bone-density finding can raise a legitimate health question without establishing that methamphetamine caused an individual fracture. A 2023 Hong Kong study is useful because it measured skeletal outcomes directly, but its exposure categories limit how specifically the results can be attributed to methamphetamine.
Who was actually studied?
Krishnamoorthy and colleagues compared 108 current or former illicit-drug users with 108 age- and sex-matched controls of Chinese ethnicity. Nineteen users identified methamphetamine as their most frequently used drug. The stimulant subgroup comprised 22 people: those 19, one cocaine user and two MDMA users. Exposure classification came from interviews, with only the most-used drug used for analysis.
“Stimulant users” therefore cannot be silently relabeled “methamphetamine-only users.” A preferred drug does not exclude other exposures. Equally, matching two groups on age and sex does not match their entire medical, nutritional or substance-use histories. That distinction matters when an expert tries to identify a single explanation for an abnormal scan.
What did the measurements show?
Dual-energy X-ray absorptiometry measured bone mineral density. In the fully adjusted stimulant subgroup, the estimated difference from controls was −0.087 g/cm² at the lumbar spine (95% confidence interval −0.146 to −0.029) and −0.074 g/cm² at the femoral neck (−0.125 to −0.022). These exploratory subgroup comparisons were not corrected for multiple testing.
The units describe a difference in measured mineral density, not the probability of breaking a bone. A confidence interval expresses statistical uncertainty around that estimated group difference; it does not identify a range within which every exposed individual falls. The small subgroup also leaves limited room to investigate differences between particular stimulants.
Did “bone strength” mean observed fractures?
No fracture-incidence outcome was measured. Hip geometry was estimated from scans. In the overall mixed-drug group, cross-sectional area, cortical thickness and narrow-neck density were lower after full adjustment; cross-sectional moment of inertia and section modulus were not statistically significant.
These distinctions prevent two expansions of the evidence. First, a collection of structural proxies is not a mechanical test in which investigators measured the force required to break participants’ bones. Second, a study of scan measurements is not a follow-up study counting new fragility fractures. The paper’s title uses “bone strength,” but the operational measurements remain essential to understanding that wording.
Can adjustment establish an independent drug effect?
The models included age, body mass index, activity, smoking, drinking and antidepressant or antipsychotic use. That is a more informative comparison than an unadjusted average alone. Adjustment nevertheless depends on what was measured and how well it was measured.
The study lacked drug-use duration and intensity measures and could not separate the independent effects of multiple drugs. Its cross-sectional design cannot establish whether an exposure preceded a skeletal change. Residual confounding remains possible. A statistically adjusted association should therefore be described as such, with the exposure definition attached.
How should this evidence inform a case review?
Separate three questions: whether the individual has an objectively documented skeletal abnormality, whether a study population resembles that person, and whether the available evidence identifies the cause. A scan report can help answer the first question. This cohort contributes to the second and generates hypotheses about the third.
It supplies no methamphetamine dose threshold, route-specific comparison or timetable for bone loss. Applying it to an individual fracture would also require the actual injury mechanism, prior skeletal measurements, relevant illnesses and medication history. This is commentary on historical observational evidence, not a screening or treatment recommendation.
Source
Krishnamoorthy S et al. Illicit drug use is associated with lower bone mineral density and bone strength. Osteoporosis and Sarcopenia. 2023;9(3):88–93. doi:10.1016/j.afos.2023.09.001. Full text. Human cross-sectional matched comparison.